Acadia Healthcare Company, Inc. ACHC
29.62 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:01 PM EST
29.62 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
29.56 Day range 30.28
11.43 52-week range 35.83
- YTD
- +108.74%
- 1 year
- +39.00%
Analyst view
Consensus: buy
Buy
Price target (mean) 33.79 +14.1% upside
Now 29.62
- Target (low)
- 17.00
- Target (mean)
- 33.79
- Target (high)
- 41.00
Ratings (0m) 14 8 buy · 5 hold · 1 sell
- Strong buy2
- Buy6
- Hold5
- Sell0
- Strong sell1
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.4644 | 0.387 – 0.55 | 0.72 | -35.5% | 877.85M | +3.1% | 12 |
| Next quarter | 0.33273 | 0.24 – 0.41 | 0.07 | +375.3% | 855.59M | +4.2% | 12 |
| Current year | 1.55 | 1.48 – 1.59 | 2.00 | -22.4% | 3.43B | +3.5% | 13 |
| Next year | 1.85 | 1.63 – 2.27 | 1.55 | +18.9% | 3.63B | +5.8% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 20, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 14, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jul 9, 2026 | UBS | Maintained | Buy | Buy |
| Jun 3, 2026 | Jefferies | Upgrade | Hold | Buy |
| May 4, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 4, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 1, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| May 1, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 28, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 17, 2026 | UBS | Maintained | Buy | Buy |
| Mar 3, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Feb 26, 2026 | UBS | Maintained | Buy | Buy |
| Feb 26, 2026 | TD Cowen | Maintained | Buy | Buy |
| Feb 26, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 23, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 22, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jan 16, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jan 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 18, 2025 | Mizuho | Maintained | Neutral | Neutral |
| Dec 4, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Dec 3, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 3, 2025 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Dec 3, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Dec 3, 2025 | UBS | Maintained | Buy | Buy |
| Dec 3, 2025 | Deutsche Bank | Maintained | Buy | Buy |